Nuclera extends Series C funding to advance antibody engineering - PharmaTimes Investment to accelerate development of full‑format antibody capabilities on eProtein Discovery system

#biologicsdiscovery #drugdiscovery #Nuclera #SeriesCfunding #antibodyengineering #eProteinDiscoverysystem #eProteinDiscovery #AIenabledproteinengineering #biologicsdiscovery #membraneproteinworkflow #Cytiva #DNA #Domainex #CROimplementation #biologicsRandD
zurl.co/lO4B9